East Africa’s healthcare industry, Katongole, holds a significant 2.79-percent stake in CiplaQCIL.
Emmanuel Katongole
-
-
CiplaQCIL’s total assets have surpassed $64 million.
- Hot News
Ugandan tycoon Emmanuel Katongole’s CiplaQCIL set to sell majority stake to Africa Capitalworks
Katongole owns a 2.79-percent equity stake in the Uganda-based pharmaceutical company.
- Hot News
Ugandan tycoon Emmanuel Katongole’s CiplaQCIL to pay shareholders first dividend in four years
Katongole owns 2.79 percent of the company, or 101,933,042 ordinary shares.
-
Katongole owns 2.79 percent of the company, which translates to 101,933,042 ordinary shares.
-
CiplaQCIL is a pharmaceutical company based in Luzira, a suburb of Kampala, the capital city of Uganda.
- Hot News
Stake of Ugandan pharma tycoon Emmanuel Katongole in CiplaQCIL rises by $200,000 since April 13
The growth in his stake follows a rise in the shares of CiplaQCIL on the Uganda Stock Exchange.